Brief: India’S Strides Pharma Science Posts Loss For March-Quarter Vs Profit Year Ago
May 25 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* MARCH-QUARTER CONSOL NET LOSS 95.4 MILLION RUPEES VERSUS
PROFIT
292.2 MILLION RUPEES
* MARCH-QUARTER CONSOL REVENUE FROM CONTINUING OPERATIONS
9.86
BILLION RUPEES VERSUS 8.66 BILLION RUPEES
* DIVIDEND 1.50 RUPEES PER SHARE
Source text for Eikon: ID:nBSE36JlBy
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees